+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Stromelysin-3 expression An independent prognostic marker in node positive breast carcinoma



Stromelysin-3 expression An independent prognostic marker in node positive breast carcinoma



Journal of Pathology 184(Suppl. ): 23A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033510657

Download citation: RISBibTeXText


Related references

Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. American Journal of Pathology 152(3): 721-728, 1998

TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer. Acta Oncologica 39(3): 327-333, 2000

The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients. Journal of Surgical Oncology 106(4): 393-398, 2012

C erb 2 expression and s phase fraction are independent prognostic factors in node positive breast cancer. Breast Cancer Research & Treatment 16(2): 182, 1990

Prognostic significance of P53 expression in node-positive breast carcinoma. Modern Pathology 8(1): 27A, 1995

Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: An immunohistochemical study. International Journal of Cancer 55(3): 429-435, 1993

Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer. Cancer Research 63(20): 6772-6783, 2003

The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer. Oncotarget 8(27): 44870-44880, 2017

The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality. Journal of BUON 20(3): 737-745, 2015

Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer 100(3): 499-506, 2004

CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clinical Cancer Research 12(21): 6421-6431, 2006

P53 as an independent prognostic marker in lymph node-negative breast cancer patients. Journal Of The National Cancer Institute (bethesda). 85(12): 965-970, 1993

CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung Cancer. Anticancer Research 38(7): 3913-3918, 2018

FOXA1 is an independent prognostic marker for ER-positive breast cancer. Breast Cancer Research and Treatment 131(3): 881-890, 2012

Moesin is an independent prognostic marker for ER-positive breast cancer. Oncology Letters 17(2): 1921-1933, 2019